Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece. - Dardiotis, Efthymios; Perpati, Georgia; Borsos, Mariann; Nikolaidis, Ioannis; Tzanetakos, Dimitrios; Deretzi, Georgia; Koutlas, Evangelos; Kilidireas, Constantinos; Mitsikostas, Dimos Dimitrios; Hadjigeorgiou, Georgios; Grigoriadis, Nikolaos; The AURELIO investigators; et al. (Neurology & Therapy, 2022)